Brazil’s Bradesco Launches US$2 Billion Capital Raise

Finance: Brazil

Bradesco’s R$10 Billion Capital Raise Splits Wall Street on Rationale

Published: August 4, 2026

Banco Bradesco is asking its own shareholders to help fund the next stage of its digital overhaul, and Wall Street cannot agree on whether that is a sign of strength or of strain.

The offering mechanics

Banco Bradesco’s board approved a capital increase of up to R$10 billion (about US$2 billion) on July 29, 2026, through the private subscription of up to 604.85 million new shares — 302.9 million common shares and 302.0 million preferred shares. The move is a rights-style private placement restricted to shareholders already on Bradesco’s register, not a public follow-on offering open to new institutional buyers, according to the bank’s material-fact filing and an SEC report (SEC 6-K filing).

New shares were priced at R$15.43 for common stock and R$17.64 for preferred stock, a 6% discount to Bradesco’s closing price on July 28, the day before the announcement, which the bank said was meant “to encourage shareholders to participate in the capital increase” (Valor International). Shareholders of record as of August 4, 2026 can exercise preemptive rights equal to 5.72% of their holdings between August 6 and September 4, with shares trading ex-rights from August 5 and the rights themselves tradable on B3 through September 1.

Controlling shareholders — holding vehicles tied to the family of founder Amador Aguiar, along with Fundação Bradesco — gave a firm commitment to subscribe up to R$8 billion, which sets the minimum threshold for the deal to proceed and guarantees the bulk of the raise regardless of minority uptake (Bloomberg). Completion still requires ratification by the Banco Central do Brasil, with no fixed delivery date yet disclosed; subscription receipts are set to begin trading on B3 from September 16.

Use of proceeds and CET1

Bradesco says the funds will support its ongoing transformation plan, financing higher spending on technology, commercial efficiency, business expansion and the bank’s sustainable-finance commitments, according to its regulatory filing (SEC 6-K filing). No legacy source describes the proceeds as earmarked for mergers or acquisitions.

The capital question sits against a backdrop of tightening ratios: Bradesco’s Common Equity Tier 1 (CET1) ratio stood at 10.2% in the first quarter of 2026, down about one percentage point from the fourth quarter, before jumping to a pro forma 12.7% after the corporate reorganization that created BradSaúde, its health-insurance unit, disclosed with first-quarter results on May 6 (Valor International).

Bradesco said that once the new capital increase is fully ratified, it should add roughly 0.9 percentage point on top of that 12.7% pro forma base, pushing CET1 toward the 13.5%-13.6% range — a buffer J.P. Morgan noted is already higher than most Brazilian bank peers even before the new shares are issued (Valor International).

Coordinator disagreement

Bradesco’s private subscription has no publicly named bookrunners, but major banks covering the stock split sharply over why the bank needs the cash at all. Goldman Sachs, in a note led by analyst Tito Labarta, called the move unexpected and said it “may raise doubts” about Bradesco’s ability to generate capital organically and about the pace at which it can absorb deferred tax assets, while keeping a Neutral rating and R$19.00 price target (Estadão/E-Investidor).

Citi struck a similarly cautious tone, judging that Bradesco may be exploiting a favorable market window to shore up capital before Brazil’s credit cycle deteriorates further, a reading that treats the raise as protective rather than purely opportunistic (Folha de S.Paulo). BTG Pactual called the announcement “surprising” and said market reactions could be mixed “since the fact that the bank is raising capital suggests it likely needed to, which was far from consensus,” while still framing the move as constructive for Bradesco’s long-term investment case (O Globo).

J.P. Morgan took the opposite view, arguing regulatory capital “is not the issue” given a pro forma CET1 of 12.7% already above most peers and roughly R$120 billion in usable deferred tax assets, and called the board’s decision correct for the long term (Valor International). One sell-side analyst told Brazil Journal the market had been positioned for a different transaction altogether: “A priori, a expectativa era de um follow-on da BradSaúde” — going in, the expectation was for a follow-on of the health unit, not a bank-level capital call (Brazil Journal).

What Bradesco investors get

Existing shareholders who exercise their full preemptive rights suffer no dilution; those who sit out face maximum dilution of about 3.4%, according to Goldman Sachs’ estimate cited in Bradesco’s own disclosure (Estadão/E-Investidor). Investors who prefer not to participate can instead sell their subscription rights on B3 between August 6 and September 1, capturing some of the discount’s value without committing fresh capital.

Bradesco built in a cash-flow bridge: it moved forward R$6.5 billion in interest on equity (JCP) payments, originally due in October 2026 and January 2027, to September 15, 2026, so shareholders can use that cash — or offset it directly — to pay for their new shares (Valor International). BTG Pactual pegged the preferred-share pre-money valuation implied by the offer price at 1.08 times book value (Brazil Journal).

The market’s first verdict was negative: Bradesco shares ranked among the Ibovespa’s biggest decliners on July 30, with BBDC3 falling as much as 2.62% to R$15.62 and BBDC4 down 2.23% to R$17.94 intraday, before paring some losses (Gazeta Mercantil). Because there is no public bookbuild, there are no over- or undersubscription figures yet; the controlling shareholders’ R$8 billion pledge already covers 80% of the maximum raise, effectively guaranteeing the deal regardless of minority-shareholder turnout.

Broader context (Brazil bank capital cycle)

Bradesco’s move comes as Brazilian banks navigate a credit cycle marked by high interest rates and rising delinquencies, even as the equity capital-markets window has reopened enough for opportunistic deals. Bradesco BBI itself said in early July there was room for follow-on offerings and block trades “in punctual windows,” even though the broader market for new share issuance remained relatively restrictive (Valor International).

The bank’s own history colors how analysts are reading the current deal. BTG Pactual pointedly noted this operation should not follow the path of Bradesco’s 2015 capital increase, part of which was later cancelled in 2016 after market volatility hit the bank’s share price (Folha de S.Paulo), an episode confirmed at the time by Reuters (Reuters via Investing.com). This time, the controlling shareholders’ upfront R$8 billion commitment is designed to remove that execution risk from the outset.

The timing also overlaps with Bradesco’s second-quarter earnings, released August 3, 2026, just days after the capital-increase announcement, giving investors a fuller picture of asset quality and provisioning trends the same week (Valor International). How that report reads on credit costs will likely shape whether the market ultimately views the R$10 billion raise as a growth investment or a hedge against a rougher credit cycle ahead of Brazil’s 2026 election season.

Frequently Asked Questions

Is Bradesco’s R$10 billion raise a public follow-on offering?

No. It is a private subscription open only to shareholders already on Bradesco’s register as of August 4, 2026. New outside investors cannot buy directly into this offering, though they could acquire shares on the open market and, separately, subscription rights are tradable on B3 for those who hold them.

Why do analysts disagree about the reason for the capital increase?

Because Bradesco already disclosed a pro forma CET1 ratio of 12.7%, above most peers, some banks such as J.P. Morgan see no regulatory necessity and view the raise as opportunistic. Others, including Citi and Goldman Sachs, argue it could reflect caution ahead of a tougher credit cycle or doubts about organic capital generation, while BTG Pactual called the move surprising but ultimately constructive.

How much will Bradesco’s capital ratio improve?

Bradesco expects the fully subscribed increase to add about 0.9 percentage point to its Common Equity Tier 1 ratio, building on the 12.7% pro forma level it disclosed in May 2026 after the BradSaúde reorganization, which would put CET1 near the mid-13% range.

Connected Coverage

More Latin America coverage from The Rio Times.

Latest News from Across Latin America

Read More from The Rio Times

• Angola’s Fuel Import Bill Hits US$1.7 Billion, Up 48%
• Itaú Sells Colombia and Panama Retail Banks to Banco de Bogotá for US$490 Million
• Copom Set to Cut Brazil’s Selic to 14.00% as Inflation Cools